Search Results - "Taylor, W. Chris"

Geriatric Assessment‐Identified Deficits in Older Cancer Patients With Normal Performance Status by Jolly, Trevor A., Deal, Allison M., Nyrop, Kirsten A., Williams, Grant R., Pergolotti, Mackenzi, Wood, William A., Alston, Shani M., Gordon, Brittaney‐Belle E., Dixon, Samara A., Moore, Susan G., Taylor, W. Chris, Messino, Michael, Muss, Hyman B.

“…Background. We investigated whether a brief geriatric assessment (GA) would identify important patient deficits that could affect treatment tolerance and care…”
Get full text

Feasibility of geriatric assessment in community oncology clinics by Williams, Grant R, Deal, Allison M, Jolly, Trevor A, Alston, Shani M, Gordon, Brittaney-Belle E, Dixon, Samara A, Olajide, Oludamilola A, Chris Taylor, W, Messino, Michael J, Muss, Hyman B

“…Abstract Objective Emerging results support the value of geriatric assessment (GA) in determining the risk and benefits of cancer treatment in older adults. A…”
Get full text

Recent advances: adjuvant therapy for older women with breast cancer by Taylor, W Chris, Muss, Hyman B

“…The U.S. population is now healthier and more long-lived than ever, and the average life expectancy for a woman born today is about 80 years. An elderly…”
Get full text

Adjuvant chemotherapy of breast cancer in the older patient by Taylor, W Chris, Muss, Hyman B

“…Although increasing age is the major risk factor for breast cancer incidence and mortality, when adjusted for disease stage, breast cancer mortality is similar…”
Get more information

High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma by Quan, Walter, Ramirez, Maria, Taylor, W Chris, Vinogradov, Mikhail, Khan, Nawazish, Jackson, Shawn

“…High-dose, continuous infusion interleukin-2 (IL-2) regimens generate greater Lymphokine Activated Killer cell (LAK) cytotoxicity in vitro and a higher rebound…”
Get more information

Repeated cycles with 72-hour continuous infusion interleukin-2 in kidney cancer and melanoma by Quan, Jr, Walter, Brick, Wendy, Vinogradov, Mikhail, Taylor, W Chris, Khan, Nawazish, Burgess, Russell

“…While high-dose bolus inpatient interleukin-2 is generally given on 8-week cycles, continuous infusion interleukin-2 could potentially allow for more rapidly…”
Get more information

Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2 by Quan, Jr, Walter D Y, Khan, Nawazish, Ramirez, Maria, Taylor, W Chris, Quan, Francine, Vinogradov, Mikhail, Walker, Paul

“…The administration of high-dose continuous intravenous infusion interleukin-2 (IL-2) is able to induce the presence of lymphokine-activated killer (LAK) cells…”
Get more information

High-Dose Continuous Infusion Plus Pulse Interleukin-2 and Famotidine in Melanoma by Quan, Walter D Y, Taylor, W Chris, Ramirez, Maria, Vinogradov, Mikhail, Khan, Nawazish, Jackson, Shawn

Get full text

Correlation between Pulmonary Edema and Response of Pulmonary Metastases to High Dose Continuous Infusion Interleukin-2 in Metastatic Melanoma and Kidney Cancer by Quan, Walter D Y, Khan, Nawazish, Taylor, W Chris, Ramirez, Maria, Vinogradov, Mikhail, Walker, Paul R

Get full text